Impact Journals Blog

Read the latest blog posts on Oncotarget and Aging

Aging

Hyperbaric Oxygen: A Therapy for Normal Aging?

Aging | June 15, 2021
Hyperbaric oxygen therapy (HBOT) provides significant benefits for patients who have suffered brain damage. In this 2020 study, researchers assessed the effects of HBOT among healthy aging participants. continue reading »

Behind the Study: Interview with Dr. Gil Atzmon

Aging | June 14, 2021
Dr. Gil Atzmon from the Albert Einstein College of Medicine discusses his 2017 study published by Aging, entitled, “The complex genetics of gait speed: genome-wide meta-analysis approach.” continue reading »

Trending with Impact: Aging and Lung Function Decline

Aging | June 10, 2021
Is there an association between biomarkers of aging and lung function? Researchers conducted a study which aimed to find out. continue reading »
View more Aging Articles

Trending

Trending with Impact: Aging and Lung Function Decline

Trending | June 10, 2021
Is there an association between biomarkers of aging and lung function? Researchers conducted a study which aimed to find out. continue reading »

Trending With Impact: Novel Urine Protein Biomarkers in Bladder Cancer

Trending | June 3, 2021
Researchers from the University of Houston and UT Southwestern Medical Center conducted a study which aimed to screen urine for potentially useful protein biomarkers of bladder cancer. continue reading »

Trending with Impact: Effects of Exercise on Aging

Trending | May 27, 2021
Researchers surveyed available literature related to exercise and its association with longevity and aging. This extensive review expands on exercise as a lifestyle intervention and its ability to counteract cellular and tissue aging. continue reading »
View more Trending Articles

Oncotarget

CRISPR Clones Shed New Light on Triple-Negative Breast Cancer

Oncotarget | June 9, 2021
Researchers used the CRISPR-Cas9 tool to learn more about the function of the mutant p53 gene in triple-negative breast cancer. continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue #12

Oncotarget | June 8, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 12. continue reading »

Behind the Study: PRAME Associated with Increased Metastatic Risk

Oncotarget | June 7, 2021
Dr. Matthew G. Field discusses his 2016 study published by Oncotarget, entitled, “Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.” continue reading »
View more Oncotarget Articles